Skip to main content
Premium Trial:

Request an Annual Quote

EditCo Bio XDel Knockout Cells

EditCo Bio has launched XDel Knockout Cells for CRISPR gene editing research. XDel technology uses a guide RNA (gRNA) design strategy to ensure robust, reliable, and reproducible gene knockout results for functional genomics, disease modeling, and drug development research, EditCo said. Specifically, the technology uses up to three "intelligently coordinated" gRNAs to create efficient and consistent fragment deletions in target genes, ensuring persistent protein depletion and eliminating the variability often encountered with single-guide methods, the company said. The cells are available in a variety of customizable formats, including cell pools, cell clones, and engineered cell libraries.